Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWood Group (J) Regulatory News (WG.)

Share Price Information for Wood Group (J) (WG.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 149.80
Bid: 150.10
Ask: 150.50
Change: 1.80 (1.22%)
Spread: 0.40 (0.266%)
Open: 148.50
High: 151.30
Low: 147.00
Prev. Close: 148.00
WG. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wood Wins Contract for Biotech Facility

23 May 2018 07:00

WOOD GROUP (JOHN) PLC - Wood Wins Contract for Biotech Facility

WOOD GROUP (JOHN) PLC - Wood Wins Contract for Biotech Facility

PR Newswire

London, May 22

23 May 2018

Wood wins contracts for Teva Biotech facility in Germany

Wood has been awarded a $US multi-million contract by TEVA Biotech GmbH to provide engineering, procurement, construction management, commissioning and qualification (EPCmQ) for a new biotechnological facility to be built in Ulm, Germany.

The plant will produce pharmaceutical ingredients from cell cultures in a new eight-storey building to be constructed within TEVA’s existing biotechnology production site.

Wood EAAA Capital Projects Group will execute detailed design and procurements services for a lump sum fee, as well as construction management and commissioning/qualification services under a reimbursable contract. Expected completion will be 2020, while tech transfer is planned to begin in 2021.

Prior to this award, Wood completed basic design and an investment cost estimate for the same facility under a previous contract, which was awarded on a competitive basis.

Robin Watson, chief executive of Wood, said: “This contract reflects TEVA’s trust in our ability to execute projects of this size in Germany and validates our global expertise in the development of active pharmaceutical ingredient facilities. We will draw upon our local knowledge, global resources, and four decades of experience working with the world’s top drug manufacturers to deliver a state-of-the-art facility to TEVA.”

This important contract increases Wood’s share in the pharmaceutical market and enhances the company’s scale and diversity in Europe.

-ends-

Note to Editors:

Wood is a global leader in the delivery of project, engineering and technical services to energy and industrial markets. We operate in more than 60 countries, employing around 55,000 people, with revenues of around $10 billion. We provide performance-driven solutions throughout the asset life cycle, from concept to decommissioning across a broad range of industrial markets, including the upstream, midstream and downstream oil & gas, power & process, environment and infrastructure, clean energy, mining, nuclear, and general industrial sectors. We strive to be the best technical services company to work with, work for and invest in. www.woodplc.com 

For further information contact: press.office@woodplc.com

Date   Source Headline
18th Aug 20232:59 pmPRNDirector/PDMR Shareholding
18th Aug 20232:58 pmPRNDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSWood signs global framework agreement with Shell
1st Aug 202312:10 pmPRNDirector Declaration
21st Jul 20232:59 pmPRNDirector/PDMR Shareholding
21st Jul 20232:58 pmPRNDirector/PDMR Shareholding
13th Jul 20237:00 amRNSHY23 trading update
3rd Jul 20237:00 amRNS$250m contract extension in Brunei
30th Jun 20232:59 pmPRNBlocklisting - Interim Review
29th Jun 20232:59 pmPRNDirector/PDMR Shareholding
16th May 20236:18 pmRNSForm 8.5 (EPT/RI)- Replacement of John Wood
16th May 20233:20 pmRNSForm 8.3 - John Wood Group plc
16th May 20233:12 pmRNSForm 8.3 - John Wood Group PLC
16th May 20231:26 pmRNSForm 8.3 - JOHN WOOD GROUP PLC
16th May 202312:33 pmRNSForm 8.3 - John Wood Group plc
16th May 202311:24 amRNSForm 8.5 (EPT/NON-RI)-John Wood Group plc
16th May 202311:24 amRNSForm 8.5 (EPT/NON-RI)-John Wood Group plc
16th May 202311:20 amRNSForm 8.5 (EPT/RI)-John Wood Group plc
15th May 20234:20 pmRNSForm 8.5 (EPT/RI)- Replacement of John Wood Group
15th May 20234:20 pmRNSForm 8.5 (EPT/RI)- Replacement of John Wood Group
15th May 20233:25 pmBUSForm 8.3 - John Wood Group plc
15th May 20233:20 pmRNSForm 8.3 - John Wood Group plc
15th May 20233:00 pmRNSForm 8.3 - John Wood Group plc
15th May 20232:46 pmRNSForm 8.3 - John Wood Group plc
15th May 20232:21 pmRNSForm 8.3 - John Wood Group plc
15th May 20232:16 pmRNSForm 8.3 - John Wood Group Plc
15th May 20231:31 pmRNSForm 8.3 - John Wood Group plc
15th May 202312:52 pmRNSForm 8.3 - John Wood Group plc
15th May 202312:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: John Wood Group plc
15th May 202312:10 pmRNSForm 8.3 - JOHN WOOD GROUP PLC
15th May 202311:44 amRNSForm 8.3 - John Wood Group plc
15th May 202311:20 amRNSForm 8.5 (EPT/NON-RI)-John Wood Group plc
15th May 202311:17 amRNSForm 8.5 (EPT/NON-RI)-John Wood Group plc
15th May 202311:14 amRNSForm 8.5 (EPT/RI)-John Wood Group plc
15th May 202310:13 amRNSForm 8.5 (EPT/RI)-John Wood Group plc
15th May 20237:03 amRNSResponse to Apollo no intention to bid statement
15th May 20237:00 amRNSStatement of Intention Not to Make an Offer
12th May 20233:25 pmBUSForm 8.3 - John Wood Group plc
12th May 20233:20 pmRNSForm 8.3 - John Wood Group plc
12th May 20233:10 pmRNSForm 8.3 - John Wood Group Plc
12th May 20233:09 pmRNSForm 8.3 - John Wood Group PLC
12th May 20233:00 pmGNWBoussard & Gavaudan Investment Management LLP: Form 8.3 - John Wood Group
12th May 20232:46 pmRNSForm 8.3 - JOHN WOOD GROUP PLC
12th May 20232:40 pmRNSForm 8.5 (EPT/RI)-Replacement of John Wood Group
12th May 20231:23 pmRNSForm 8.3 - John Wood Group Plc
12th May 202311:39 amRNSForm 8.3 - John Wood Group plc
12th May 202311:35 amBUSForm 8.3 - John Wood Group plc
12th May 202311:26 amRNSForm 8.3 - John Wood Group Plc
12th May 202311:04 amRNSForm 8.5 (EPT/RI)- John Wood Group plc
12th May 202310:47 amRNSForm 8.5 (EPT/RI)-John Wood Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.